Deltex Medical Group PLC Partial redemption of convertible loan note (4995O)
May 18 2018 - 1:00AM
UK Regulatory
TIDMDEMG
RNS Number : 4995O
Deltex Medical Group PLC
18 May 2018
18 May 2018
Deltex Medical Group plc
("Deltex" or "the Company")
Partial redemption of convertible loan note
Deltex Medical Group plc (AIM: DEMG), the global leader in
Oesophageal Doppler Monitoring ("ODM"), gives notice that it has
issued 2,000,000 New Ordinary Shares of 1p each at a price of 1.25p
each, equal to the closing share price on 17 May 2018.
As stated in the Company's shareholder circular (the
"Circular"), published on 24 January 2018, it was agreed that a
holding of GBP25,000 nominal amount of convertible loan notes could
be redeemed. The holder of these convertible loan notes requested
that the nominal amount be reinvested in the Company at the same
price as the fundraising in January. In the light of this, the
Directors have allotted 2,000,000 New Ordinary Shares of 1p each
using the allotment authorities granted to the Directors at the
annual general meeting of the Company on 9 June 2017.
It is expected that the Admission of the 2,000,000 New Ordinary
Shares of 1p will become effective at 8.00 a.m. on 24 May 2018.
Following Admission, the total number of Ordinary Shares in
issue with voting rights will be 492,663,367 Ordinary Shares.
Shareholders may use this figure as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or change to their interest in, the share
capital of the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information, please contact:-
Deltex Medical Group plc 01243 774 837
investorinfo@deltexmedical.com
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Jonathan Shaw, Group Finance
Director
Nominated Adviser & Broker
Arden Partners plc 020 7614 5900
Chris Hardie
Ciaran Walsh
Joint Broker
Turner Pope Investments (TPI) 0203 621 4120
Ltd info@turnerpope.com
Andy Thacker
Financial Public Relations
IFC Advisory Ltd 0203 934 6630
Tim Metcalfe
Graham Herring
Heather Armstrong
Notes for Editors
Deltex manufactures and markets haemodynamic monitoring
technologies. Deltex's proprietary ODM (TrueVue(TM) Doppler) is the
only technology to measure blood flow in the central circulation in
real time. Minimally invasive, easy to set up and quick to focus,
the technology generates a low-frequency ultrasound signal, which
is highly sensitive to changes in flow and measures them
immediately. Deltex has been the only Group in the enhanced
haemodynamic space to build a robust and credible evidence base
proving the clinical and economic benefits of its core technology,
TrueVue(TM) Doppler which is proven to reduce complications
suffered by patients after surgery and save hospitals the costs of
treating those complications.
Deltex's TrueVue(TM) System on the CardioQ-ODM+ monitor platform
also now provides clinicians with two further advanced haemodynamic
monitoring technologies. High Definition Impedance Cardiography is
an entirely non-invasive monitoring technology which creates an
electrical field across the chest and measures the disruption to
this field when the heart pumps blood. Pulse Pressure Waveform
Analysis uses peripheral blood pressure signal analysis to give
doctors information on changes in the circulation and is
particularly suited to monitoring lower risk or haemodynamically
stable patients.
Group goal
Haemodynamic management is now becoming widely accepted as an
important major new medical modality. Consequently, the Group's
focus is on maximising value from the opportunities presented as
enhanced haemodynamic management is adopted into routine clinical
practice around the world. The Group aims to provide clinicians
with a single platform, a 'haemodynamic workstation', which offers
them a range of technologies from simple to sophisticated to be
deployed according to the patient's condition and skill and
expertise of the user. Doing this will enable the Group to partner
healthcare providers to support modern haemodynamic management
across the whole hospital.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEUBVRRWOAVAUR
(END) Dow Jones Newswires
May 18, 2018 02:00 ET (06:00 GMT)
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From Apr 2024 to May 2024
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From May 2023 to May 2024